IMMUCOR INC
DelistedCIK 736822fmd_0B61XM8BSZYMXETZYKGFARG9YXManufacturing · In Vitro & In Vivo Diagnostic SubstancesTemplate: Standard
Coverage: Jun 01, 2008 to Feb 28, 2017, 32 periods
Latest annual · FY2016
Millions- Total revenues
- 380
- Gross profit
- 236
- Operating income
- 29
- Net income
- (42)
- Free cash flow
- 17
Latest quarter · Q3 FY2017
Millions- Total revenues
- 94
- Gross profit
- 59
- Operating income
- 8
- Net income
- (8)
- Free cash flow
- (9)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2013 to FY2016
- +3.0%
- Revenue, 5 yearsFY2010 to FY2016
- +2.9%
- Net income, 5 yearsFY2010 to FY2016
- n/m
IMMUCOR INC financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2016 | FY2015 | Change | Source |
|---|---|---|---|---|
| Revenue | $380 million | $389.3 million | -2.4% | 10-K 2016-08-22 · proof |
| Gross profit | $236 million | $245.6 million | -3.9% | 10-K 2016-08-22 · proof |
| Operating income | $28.9 million | $43.3 million | -33.2% | 10-K 2016-08-22 · proof |
| Net income | -$42.1 million | -$60.7 million | 10-K 2016-08-22 · proof | |
| Cash from operating activities | $27.1 million | $25.6 million | +5.9% | 10-K 2016-08-22 · proof |
| Free cash flow | $17.2 million | $14.2 million | +20.9% | 10-K 2016-08-22 · proof |
| Total assets | $1.7 billion | $1.7 billion | -0.7% | 10-K 2016-08-22 · proof |
| Total liabilities | $1.4 billion | $1.3 billion | +2% | 10-K 2016-08-22 · proof |
| Cash and cash equivalents | $10.3 million | $18.4 million | -44.1% | 10-K 2016-08-22 · proof |
| Total debt | $1 billion | $1 billion | +0.3% | 10-K 2016-08-22 · proof |
- What was IMMUCOR INC's revenue in fiscal 2016?
- IMMUCOR INC reported revenue of $380 million for fiscal 2016 (the year ended May 31, 2016), against $389.3 million the year before (-2.4%). Source: the 10-K filed with the SEC on Aug 22, 2016. SEC
- What was IMMUCOR INC's gross profit in fiscal 2016?
- IMMUCOR INC reported gross profit of $236 million for fiscal 2016 (the year ended May 31, 2016), against $245.6 million the year before (-3.9%). Source: the 10-K filed with the SEC on Aug 22, 2016. SEC
- What was IMMUCOR INC's operating income in fiscal 2016?
- IMMUCOR INC reported operating income of $28.9 million for fiscal 2016 (the year ended May 31, 2016), against $43.3 million the year before (-33.2%). Source: the 10-K filed with the SEC on Aug 22, 2016. SEC
- What was IMMUCOR INC's net income in fiscal 2016?
- IMMUCOR INC reported net income of -$42.1 million for fiscal 2016 (the year ended May 31, 2016), against -$60.7 million the year before. Source: the 10-K filed with the SEC on Aug 22, 2016. SEC
- What was IMMUCOR INC's cash from operating activities in fiscal 2016?
- IMMUCOR INC reported cash from operating activities of $27.1 million for fiscal 2016 (the year ended May 31, 2016), against $25.6 million the year before (+5.9%). Source: the 10-K filed with the SEC on Aug 22, 2016. SEC
- What was IMMUCOR INC's free cash flow in fiscal 2016?
- IMMUCOR INC reported free cash flow of $17.2 million for fiscal 2016 (the year ended May 31, 2016), against $14.2 million the year before (+20.9%). Source: the 10-K filed with the SEC on Aug 22, 2016. SEC
- What are IMMUCOR INC's total assets?
- As of May 31, 2016, IMMUCOR INC reported total assets of $1.7 billion, against $1.7 billion a year earlier (-0.7%). Source: the 10-K filed with the SEC on Aug 22, 2016. SEC
- What are IMMUCOR INC's total liabilities?
- As of May 31, 2016, IMMUCOR INC reported total liabilities of $1.4 billion, against $1.3 billion a year earlier (+2%). Source: the 10-K filed with the SEC on Aug 22, 2016. SEC
- What are IMMUCOR INC's cash and cash equivalents?
- As of May 31, 2016, IMMUCOR INC reported cash and cash equivalents of $10.3 million, against $18.4 million a year earlier (-44.1%). Source: the 10-K filed with the SEC on Aug 22, 2016. SEC
- What is IMMUCOR INC's total debt?
- As of May 31, 2016, IMMUCOR INC reported total debt of $1 billion, against $1 billion a year earlier (+0.3%). Source: the 10-K filed with the SEC on Aug 22, 2016. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:736822&period_type=annual&limit=5"Information only, not investment advice.